Bremelanotide

Category: Melanocortin receptor agonist

Studied or approved for: Hypoactive sexual desire disorder in premenopausal women (Vyleesi)

Regulatory status: FDA-APPROVED for that indication only.

Typical administration: Injection as needed

Educational purposes only — not medical advice. Peptiverse.net does not sell or prescribe peptides. Consult a qualified healthcare professional. Full disclaimer: /disclaimer/.